

Reviva Pharmaceuticals shares are tumbling Thursday after pricing a $10 million public offering of over 6 million shares at $1.50 per share.
You can purchase shares of REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (OTCQB:RVPH) through any online brokerage.
There are no as such competitors for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc..
REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. has a consensus price target of $123.44.
The stock price for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (OTCQB: RVPH) is $0.3676 last updated November 6, 2026 at 3:59 PM EST.
There are no upcoming dividends for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc..
REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc..
REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and...